CT:IQ has launched a practical tool to help research sites navigate the challenges of recruiting participants for clinical trials. The CT:IQ GREET project (Guidance to Recruitment Examining Experiences at Trial sites) identified barriers and enablers to recruitment at a site level and developed best practice recommendations in the form of the Clinical Trial Site Recruitment Guide. It is widely accepted and recognised that clinical […]
CT:IQ, a collaborative of Australian clinical trial stakeholders who aim to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, is excited to launch the Early Phase Trials Best Practice Checklist. The checklist was developed as a single source of best practice recommendations, tools and resources to help ensure […]
Our priority is the safety and wellbeing of our talented staff, CT:IQ members, our stakeholders and their families in the current environment. Following the declaration of the COVID-19 (coronavirus) pandemic, CT:IQ have transitioned to a work from home arrangement for the time being. As part of the social distancing measures we are implementing, we now […]
Join us for a free webinar on Wednesday 18 September with Praxis Australia and learn about CT:IQ’s clinical trial projects, future plans and the benefits of becoming a CT:IQ member. CT:IQ are conducting five projects in 2019 selected and prioritised against the needs of the sector by our Steering Committee members in the following areas: […]
Evrima Technologies transforms clinical trial recruitment by connecting researchers, clinicians and patients together to accelerate research and bring new treatments to patients who need them.
The “South Australia Clinical Trials Group” is a collection of organisations which includes University of Adelaide, University of South Australia, Flinders University, SA Health Department for Health and Wellbeing, SA Health and Medical Research Institute and the Central Adelaide Local Health Network.
NSW Health aims to establish NSW as a global centre of excellence in health and medical research innovation.
The Patient Voice Initiative (PVI) represents stakeholders from industry, academia and consumers advocacy groups.
GSK is a science-led global healthcare company with an ambitious mission to help people do more, feel better and live longer. GSK has three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
A medical technology company that develops trusted and innovative cardiovascular and endovascular solutions